CS logo
small CS logo
Samaritan Hematology & Oncology Consultants

Corvallis, Oregon, United States
Medical clinic in Corvallis, Oregon
501 NW Elks Dr Suite 100, Corvallis, OR 97330

About Samaritan Hematology & Oncology Consultants


"Samaritan Hematology & Oncology Consultants - Corvallis provides expert, accredited cancer care. As part of the Samaritan Cancer Program, medical oncologists diagnose and treat all types of cancer with a variety of options including chemotherapy, hormonal therapy and biological therapy. The clinic is located within the Samaritan Pastega Regional Cancer Center."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Samaritan Hematology & Oncology Consultants


During the past decade, Samaritan Hematology & Oncology Consultants conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Samaritan Hematology & Oncology Consultants


According to Clinical.Site data, the most researched conditions in "Samaritan Hematology & Oncology Consultants" are "Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Samaritan Hematology & Oncology Consultants" in a lesser frequency.

Clinical Trials Intervention Types at Samaritan Hematology & Oncology Consultants


Most popular intervention types in "Samaritan Hematology & Oncology Consultants" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Dacomitinib (PF-00299804)" (1 trials), "Placebo PF00299804" (1 trials), "Placebo erlotinib" (1 trials) and "neratinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Samaritan Hematology & Oncology Consultants


The vast majority of trials in "Samaritan Hematology & Oncology Consultants" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Samaritan Hematology & Oncology Consultants


Currently, there are NaN active trials in "Samaritan Hematology & Oncology Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Samaritan Hematology & Oncology Consultants, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Samaritan Hematology & Oncology Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".